With the U.S. facing a projected shortage of 1,630 gastroenterologists by 2025, healthcare leaders are increasingly focused on recruitment challenges and costs.A new AMN Healthcare report, The Cost of Physician Turnover and the Economic Impact of Physicians, details the significant expenses associated with onboarding a gastroenterologist: Salary: $531,000Signing bonus: $46,000
Author: Abhay Panchal
Guthrie has partnered with Gastroenterology Associates of Ithaca (GAI) to enhance gastroenterological care in Tompkins County. While GAI patients will continue office visits at their current location, endoscopic procedures will now take place at Guthrie’s state-of-the-art GI suite in Ithaca City Harbor or Guthrie Cortland Medical Center. The collaboration, effective March 3, ensures continuity of care with all existing insurance plans accepted. Leaders from both organizations emphasize the partnership’s alignment in providing high-quality GI services and improving patient experience in the region.
Supergut, a gut health brand specializing in GLP-1 nutrition, has secured a significant growth investment from Full Frame Growth Partners and appointed former Vital Proteins CEO, Tracey Warner Halama, as its new CEO, while founder Marc Washington transitions to a strategic role. With sales surging 172% in 2024, Supergut is expanding its retail presence in Target, Sprouts, and GNC, offering clinically backed shakes, bars, and powders that support gut health and naturally stimulate GLP-1 hormone production. The brand aims to strengthen its position in the digestive health category, grow on Amazon, and potentially conduct further clinical research on its GLP-1…
Season 2 of Brains & Guts explores the evolving AI landscape in gastroenterology. The first episode features Dr. Aasma Shaukat, professor of medicine at NYU Grossman School of Medicine and ACG Board of Trustees member, discussing AI’s impact on GI care.
At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
At the Paris AI Summit, U.S. Vice President J.D. Vance urged against overregulating AI, arguing that excessive caution could stifle innovation. This shift in perspective aligns with rapid advancements, including DeepSeek’s open-source AI models, which significantly reduce development costs and lower entry barriers for smaller companies. In healthcare, knowledge distillation—training AI on real-world patient interactions—is set to drive hyper-specialized AI applications. This could transform virtual care, improve chronic disease management, and reduce healthcare costs. AI-powered assistants trained on real patient data may soon provide scalable, affordable care, filling critical gaps without replacing human clinicians.
Cylinder, a leading virtual digestive health provider, has appointed Ryan Sloan as its first Chief Commercial Officer (CCO) to oversee sales, health plan partnerships, and commercial strategy. With over 20 years of experience in healthcare, Sloan has held key roles at Galileo, Google’s Onduo, Aetna, and Vitality, specializing in digital health and value-based care.
Key takeaways: Among populations with low adherence to colorectal cancer screening, annual fecal immunochemical testing was the cheapest and most effective noninvasive screening method, according to a study published in JAMA Network Open.
his World Obesity Day, the focus shifts from individuals to systemic factors shaping health, such as policy, healthcare systems, and social determinants like food security. A new commission in The Lancet Diabetes & Endocrinology calls for a shift away from BMI as the primary diagnostic tool for obesity, introducing ‘preclinical obesity’ and ‘clinical obesity’ to better classify disease progression. Similarly, experts argue that metabolic dysfunction-associated steatotic liver disease (MASLD) should be classified as a non-communicable disease (NCD) alongside cardiovascular disease, diabetes, cancer, and chronic respiratory disease. With MASLD affecting 30% of the global population, integrating it into public health strategies…
On February 21, 2025, the FDA declared the semaglutide shortage resolved, stating that supply now meets or exceeds demand. This decision follows ongoing litigation with the Outsourcing Facilities Association (OFA), which filed a new lawsuit challenging the removal. The FDA has extended compounding allowances for state-licensed pharmacies until April 22, 2025, and outsourcing facilities until May 22, 2025. The legal battle over semaglutide’s availability may impact future compounding policies, especially as certain GLP-1 products continue to be compounded in various formulations.